1. Home
  2. SHIM vs KRRO Comparison

SHIM vs KRRO Comparison

Compare SHIM & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shimmick Corporation

SHIM

Shimmick Corporation

N/A

Current Price

$3.35

Market Cap

160.8M

Sector

N/A

ML Signal

N/A

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

N/A

Current Price

$14.22

Market Cap

187.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SHIM
KRRO
Founded
1990
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
160.8M
187.9M
IPO Year
2023
2019

Fundamental Metrics

Financial Performance
Metric
SHIM
KRRO
Price
$3.35
$14.22
Analyst Decision
Buy
Analyst Count
0
12
Target Price
N/A
$34.80
AVG Volume (30 Days)
157.6K
90.5K
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
81.95
N/A
EPS
N/A
N/A
Revenue
$492,844,000.00
$6,392,000.00
Revenue This Year
$13.99
N/A
Revenue Next Year
$6.94
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.63
181.46
52 Week Low
$1.95
$5.20
52 Week High
$6.76
$55.89

Technical Indicators

Market Signals
Indicator
SHIM
KRRO
Relative Strength Index (RSI) 39.11 60.41
Support Level $2.49 $9.76
Resistance Level $4.09 $14.42
Average True Range (ATR) 0.26 0.95
MACD -0.04 0.12
Stochastic Oscillator 14.04 71.95

Price Performance

Historical Comparison
SHIM
KRRO

About SHIM Shimmick Corporation

Shimmick Corp is engaged in delivering turnkey infrastructure solutions that strengthen critical markets across water, energy, climate resiliency, and sustainable transportation. It selectively focuses on the following types of infrastructure projects: Water Treatment, Water Resources, and Other Critical Infrastructure. In water treatment projects the company expands, rehabilitates, upgrades, builds and rebuilds water and wastewater treatment infrastructure. In Other Critical Infrastructure projects, It builds, retrofits, expands, rehabilitates, operates, and maintains critical infrastructure, including mass transit, bridges, and military infrastructure. The company has one operating and reportable segment: infrastructure solutions. All of its revenue is derived from the United States.

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.

Share on Social Networks: